AU2003303591A1 - Pharmaceutical compositions with improved dissolution - Google Patents

Pharmaceutical compositions with improved dissolution

Info

Publication number: AU2003303591A1
Authority: AU; Australia
Prior art keywords: pharmaceutical compositions; improved dissolution; dissolution; improved; pharmaceutical
Prior art date: 2002-12-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003303591A

Inventor

Orn Almarsson

Hongming Chen

Hector Guzman

Mark Oliveira

Matthew Peterson

Julius Remenar

Mark Tawa

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Transform Pharmaceuticals Inc

Original Assignee

Transform Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-30

Filing date

2003-12-24

Publication date

2004-07-29

2003-06-20 Priority claimed from PCT/US2003/019574 external-priority patent/WO2004000284A1/en

2003-09-04 Priority claimed from PCT/US2003/027772 external-priority patent/WO2004078161A1/en

2003-09-11 Priority claimed from US10/660,202 external-priority patent/US7927613B2/en

2003-09-16 Priority claimed from PCT/US2003/028982 external-priority patent/WO2004026235A2/en

2003-12-24 Application filed by Transform Pharmaceuticals Inc filed Critical Transform Pharmaceuticals Inc

2003-12-24 Priority claimed from PCT/US2003/041273 external-priority patent/WO2004061433A1/en

2004-07-29 Publication of AU2003303591A1 publication Critical patent/AU2003303591A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Investigating Or Analysing Materials By Optical Means (AREA)
Medicinal Preparation (AREA)

AU2003303591A 2002-12-30 2003-12-24 Pharmaceutical compositions with improved dissolution Abandoned AU2003303591A1 (en)

Applications Claiming Priority (27)

Application Number	Priority Date	Filing Date	Title
US43751602P	2002-12-30	2002-12-30
US60/437,516		2002-12-30
US44133503P	2003-01-21	2003-01-21
US60/441,335		2003-01-21
US45121303P	2003-02-28	2003-02-28
US60/451,213		2003-02-28
US45602703P	2003-03-18	2003-03-18
US60/456,027		2003-03-18
US45660803P	2003-03-21	2003-03-21
US60/456,608		2003-03-21
US45950103P	2003-04-01	2003-04-01
US60/459,501		2003-04-01
PCT/US2003/019574 WO2004000284A1 (en)	2002-06-21	2003-06-20	Pharmaceutical compositions with improved dissolution
AUPCT/US2003/019574		2003-06-20
US10/601,092 US20050025791A1 (en)	2002-06-21	2003-06-20	Pharmaceutical compositions with improved dissolution
US10/601,092		2003-06-20
US48706403P	2003-07-11	2003-07-11
US48671303P	2003-07-11	2003-07-11
US60/486,713		2003-07-11
US60/487,064		2003-07-11
PCT/US2003/027772 WO2004078161A1 (en)	2003-02-28	2003-09-04	Pharmaceutical co-crystal compositions of drugs such as carbamazeptine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
AU2003272270		2003-09-04
US10/660,202 US7927613B2 (en)	2002-02-15	2003-09-11	Pharmaceutical co-crystal compositions
US10/660,202		2003-09-11
AU2003267231		2003-09-16
PCT/US2003/028982 WO2004026235A2 (en)	2002-09-20	2003-09-16	Pharmaceutical compositions with improved dissolution
PCT/US2003/041273 WO2004061433A1 (en)	2002-12-30	2003-12-24	Pharmaceutical compositions with improved dissolution

Publications (1)

Publication Number	Publication Date
AU2003303591A1 true AU2003303591A1 (en)	2004-07-29

Family

ID=46124010

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003303591A Abandoned AU2003303591A1 (en)	2002-12-30	2003-12-24	Pharmaceutical compositions with improved dissolution

Country Status (4)

Country	Link
EP (1)	EP1579198A1 (en)
JP (1)	JP5021934B2 (en)
AU (1)	AU2003303591A1 (en)
CA (1)	CA2511881C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009059605A1 (en) *	2007-11-08	2009-05-14	University Of Copenhagen	Small scale solid state screening
GB0813709D0 (en) *	2008-07-26	2008-09-03	Univ Dundee	Method and product
JP2015531785A (en) *	2012-09-13	2015-11-05	シービーエー・ファーマ・インコーポレイテッドＣｂａＰｈａｒｍａ，Ｉｎｃ．	Tetrandrine pharmaceutical formulation and method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2236011T3 (en) *	1999-12-08	2005-07-16	Pharmacia Corporation	CELECOXIB POLYMORPHIC CRYSTAL FORMS.
CZ20022332A3 (en) *	2000-01-07	2003-01-15	Transform Pharmaceuticals, Inc.	Sample assembly
US7115565B2 (en) *	2001-01-18	2006-10-03	Pharmacia & Upjohn Company	Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
US20040127537A1 (en) *	2002-06-26	2004-07-01	Gokarn Yatin R.	Stable liquid parenteral parecoxib formulation
US20040092566A1 (en) *	2002-11-12	2004-05-13	Graneto Matthew J.	Celecoxib prodrug

2003
- 2003-12-24 AU AU2003303591A patent/AU2003303591A1/en not_active Abandoned
- 2003-12-24 CA CA2511881A patent/CA2511881C/en not_active Expired - Fee Related
- 2003-12-24 EP EP03808567A patent/EP1579198A1/en not_active Withdrawn
- 2003-12-24 JP JP2005508617A patent/JP5021934B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2511881A1 (en)	2004-07-22
JP2006517527A (en)	2006-07-27
JP5021934B2 (en)	2012-09-12
CA2511881C (en)	2013-06-25
EP1579198A1 (en)	2005-09-28

Publication	Publication Date	Title
AU2009201465A1 (en)	2009-05-07	Pharmaceutical Compositions with Improved Dissolution
AU2003291103A1 (en)	2004-06-15	Pharmaceutical composition
GB0213739D0 (en)	2002-07-24	Pharmaceutical compositions
IL164547A0 (en)	2005-12-18	Pharmaceutical composition
AU2003250372A1 (en)	2004-01-06	Pharmaceutical composition
GB0218004D0 (en)	2002-09-11	Pharmaceutical compositions
AU2003260803A1 (en)	2004-03-19	Sustained release pharmaceutical composition
AU2003267231A1 (en)	2004-04-08	Pharmaceutical compositions with improved dissolution
GB0213481D0 (en)	2002-07-24	Pharmaceutical compositions
AU2003284460A1 (en)	2004-06-23	Medicinal composition
AU2003216503A1 (en)	2003-09-22	Stable pharmaceutical compositions
AU2003303591A1 (en)	2004-07-29	Pharmaceutical compositions with improved dissolution
AU2003280678A1 (en)	2004-05-25	Medicinal composition
AUPS188302A0 (en)	2002-05-30	Pharmaceutical composition
HK1078339A (en)	2006-03-10	Pharmaceutical compositions with improved dissolution
GB0217703D0 (en)	2002-09-11	Pharmaceutical composition
AU2002335161A1 (en)	2004-04-30	Medicinal composition
AUPS167102A0 (en)	2002-05-16	Pharmaceutical composition
AUPS124202A0 (en)	2002-04-18	Pharmaceutical composition
HK1073611A (en)	2005-10-14	Pharmaceutical compositions
HK1071299A (en)	2005-07-15	Stable pharmaceutical compositions
AU2003242346A1 (en)	2004-01-19	Drug composition
HK1089377A (en)	2006-12-01	Pharmaceutical composition
HK1088245A (en)	2006-11-03	Pharmaceutical composition
AU2003902322A0 (en)	2003-05-29	Pharmaceutical composition

Legal Events

Date	Code	Title	Description
2005-10-13	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase